Share:
Original Article

Study of Nail Psoriasis and Dermoscopic Correlation With Dermoscopic and Modified Dermoscopic Nail Psoriasis Severity Indexes (dNAPSI and dmNAPSI)

    Sandeep Arora   Bio
    ; Debatraya Paul Bio
    ; Richa Kumar Bio
    ; Sunita Mech Bio
    ; Devinder Kumar Suhag Bio

Author Affiliation(s)

Abstract

Background: Nail involvement in psoriasis may be assessed clinically, ultrasonologically, and dermoscopically. The aim of this study was to assess the dermoscopic features of nails in psoriasis, compare them with clinical findings, and correlate them with the Nail Psoriasis Severity Index (NAPSI) score.


Methods: We recruited 120 patients with psoriatic nail changes for the study. The Psoriasis Area Severity Index (PASI) was used to assess the severity of disease. Clinical and dermoscopic (DermLite DL4, ×10, polarized and non-polarized) nail examination determined NAPSI, modified NAPSI (mNAPSI), and NAPSI determined with dermoscopic findings (dermoscopic NAPSI [dNAPSI] and dermoscopic modified NAPSI [dmNAPSI]) were used to assess severity of nail involvement.


Results: Subungual hyperkeratosis (50.8%) and nail plate thickening (56.7%) were the commonest clinical nail changes found, and dermoscopically, they were subungual hyperkeratosis and pitting (68.3% each). The average median with interquartile range of PASI and NAPSI scores were 7.5 [5.7-10.8] and 8.0 [6-12], respectively. NAPSI scores increased significantly with the increase in PASI scores (P < 0.001). A comparison of NAPSI and mNAPSI with dNAPSI and dmNAPSI revealed that NAPSI, mNAPSI, and dNAPSI increased significantly with an increase in PASI scores. dNAPSI scores increased significantly with increased mNAPSI and dmNAPSI, and mNAPSI and dmNAPSI were significantly good predictors of joint involvement in psoriasis.


Conclusions: Dermoscopy allows for better visualization of nail findings. Evaluating NAPSI and mNAPSI scores in conjunction with dNAPSI and dmNAPSI increases their helps detect early psoriasis, detection of worsening moderate-to-severe psoriasis (PASI >10) and predict joint involvement and their severity

Keywords : nail psoriasis, nail psoriasis severity index, psoriasis area severity index, dermoscopy, onychoscopy

References

1. de Jong EM, Seegers BA, Gulinck MK, Boezeman JB, van de Kerkhof PC. Psoriasis of the nails associated with disability in a large number of patients: results of a recent interview with 1,728 patients. Dermatology. 1996;193(4):300-303. DOI: 10.1159/000246274. PMID: 8993953. 2. Reich A, Szepietowski JC. Health-Related Quality of Life in Patients with Nail Disorders. Am J Clin Dermatol. 2011;12(5):313-320. DOI: 10.2165/11592120-000000000-00000. PMID: 21834596. 3. Dogra A, Arora AK. Nail Psoriasis: The Journey So Far. Indian J Dermatol. 2014;59(4):319-333. DOI: 10.4103/0019-5154.135470. PMID: 25071247; PMCID: PMC4103264. 4. Schons KRR, Beber AAC, Beck M de O, Monticielo OA. Nail involvement in adult patients with plaque-type psoriasis: prevalence and clinical features. An Bras Dermatol. 2015;90(3):314-319. DOI: 10.1590/abd1806-4841.20153736. PMID: 26131859; PMCID: PMC4516108. 5. Reich K. Approach to managing patients with nail psoriasis. J Eur Acad Dermatol Venereol. 2009;23 Suppl 1:15-21. DOI: 10.1111/j.1468-3083.2009.03364.x. PMID: 19686381. 6. Salomon J, Szepietowski JC, Proniewicz A. Psoriatic nails: a prospective clinical study. J Cutan Med Surg. 2003;7(4):317-321. DOI: 10.1007/s10227-002-0143-0. PMID: 12879333. 7. Edwards F, de Berker D. Nail psoriasis: clinical presentation and best practice recommendations. Drugs. 2009;69(17):2351-2361. DOI: 10.2165/11318180-000000000-00000. PMID: 19911853. 8. Jiaravuthisan MM, Sasseville D, Vender RB, Murphy F, Muhn CY. Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy. J Am Acad Dermatol. 2007;57(1):1-27. DOI: 10.1016/j.jaad.2005.07.073. PMID: 17572277. 9. Gupta AK, Cooper EA. Psoriatic nail disease: quality of life and treatment. J Cutan Med Surg. 2009;13 Suppl 2:S102-S106. DOI: 10.2310/7750.2009.00027. PMID: 1979982. 10. Micali G, Lacarrubba F, Massimino D, Schwartz RA. Dermatoscopy: Alternative uses in daily clinical practice. J Am Acad Dermatol. 2011;64(6):1135-1146. DOI: 10.1016/j.jaad.2010.03.010. PMID: 21292346. 11. Farias DC de, Tosti A, Chiacchio ND, Hirata SH. [Dermoscopy in nail psoriasis]. An Bras Dermatol. 2010;85(1):101-103. DOI: 10.1590/s0365-05962010000100017. PMID: 20464097. 12. Polat A, Kapıcıoğlu Y. Dermoscopic findings of psoriatic nail and their relationship with disease severity. TURKDERM. 2017;51:119–23. DOI: 10.4274/turkderm.54289. 13. Yorulmaz A, Artuz F. A study of dermoscopic features of nail psoriasis. Postepy Dermatol Alergol. 2017;34(1):28-35. DOI: 10.5114/ada.2017.65618. PMID: 28286468; PMCID: PMC5340855. 14. Yadav TA, Khopkar US. Dermoscopy to Detect Signs of Subclinical Nail Involvement in Chronic Plaque Psoriasis: A Study of 68 Patients. Indian J Dermatol. 2015;60(3):272-275. DOI: 10.4103/0019-5154.156377. PMID: 26120154; PMCID: PMC4458939. 15. Prabhakar V, Joy B, Thyvalappil A, Sridharan R, Sreenivasan A, Mathew P. Prevalence, clinical profile, and severity of nail involvement in psoriasis – A hospital-based cross-sectional study from a tertiary care center in North Kerala. J Skin Sex Transm Dis 2019;1(2):72-6. 16. Elobeid HE, Alfarouk KO, Ahmed N. Aljarbou AN, et al. Correlation between the Body Mass Index and Psoriasis in Dermatology and Venereology Teaching Hospital in Khartoum. AJDV. 2017;6:30–39. doi:10.5923/j.ajdv.20170602.03 17. Misra A. Ethnic-Specific Criteria for Classification of Body Mass Index: A Perspective for Asian Indians and American Diabetes Association Position Statement. Diabetes Technol Ther. 2015;17(9):667-671. doi:10.1089/dia.2015.0007 18. The Etiology, Pathophysiology,Differential Diagnosis, Clinical Findings, and Treatment of Nail Psoriasis | IntechOpen [Internet]. [cited 2020 Jun 17]. Available from: https://www.intechopen.com/chapters/66296 19. Farber EM, Nall ML. The natural history of psoriasis in 5,600 patients. Dermatologica. 1974;148(1):1-18. DOI: 10.1159/000251595. PMID: 4831963. 20. Armesto S, Esteve A, Coto-Segura P, et al. [Nail psoriasis in individuals with psoriasis vulgaris: a study of 661 patients]. Actas Dermosifiliogr. 2011;102(5):365-72. DOI: 10.1016/j.ad.2011.02.007. PMID: 21514549. 21. Baran R. The burden of nail psoriasis: an introduction. Dermatology. 2010;221 Suppl 1:1-5. DOI: 10.1159/000316169. PMID: 20733309. 22. Wanniang N, Navya A, Pai V, Ghodge R. Comparative study of clinical and dermoscopic features in nail psoriasis. Indian Dermatol Online J. 2020;11(1):35-40. DOI: 10.4103/idoj.IDOJ_51_19. PMID: 32055506; PMCID: PMC7001394. 23. Hallaji Z, Babaeijandaghi F, Akbarzadeh M, et al. A significant association exists between the severity of nail and skin involvement in psoriasis. J Am Acad Dermatol. 2012;66(1):e12-13. DOI: 10.1016/j.jaad.2010.10.021. PMID: 22177647. 24. Prevezas C, Katoulis AC, Papadavid E, Panagakis P, Rigopoulos D. Short-Term Correlation of the Psoriasis Area Severity Index, the Nail Psoriasis Area Severity Index, and the Dermatology Life Quality Index , before and after Treatment, in Patients with Skin and Nail Psoriasis. Skin Appendage Disord. 2019;5(6):344-349. DOI: 10.1159/000499348.. PMID: 31799260; PMCID: PMC6883452. 25. Cassell S, Bieber J, Rich P, et al. The modified Nail Psoriasis Severity Index: Validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis. J Rheumatol. 2007;34(1):123-129. PMID: 17216680.

Send mail to Author


Send Cancel